PB2343: TRIAL IN PROGRESS: PHASE 3 TRIAL EVALUATING THE EFFICACY AND SAFETY OF ODRONEXTAMAB VERSUS STANDARD OF CARE THERAPY IN RELAPSED/REFRACTORY AGGRESSIVE B-CELL NON-HODGKIN LYMPHOMA (OLYMPIA-4) - Eliza A. Hawkes; Tae Min Kim; Manjusha Namuduri; Ashish Risal; Biyi Shen; Dina Flink; Min Zhu; Siobhán Nolan; Jurriaan Brouwer-Visser; Aafia Chaudhry; Srikanth Ambati; Hesham Mohamed; et al. (HemaSphere, 2023)